Badrul Chowdhury, MD/PhD, named permanent director of CDER's Division of Pulmonary & Allergy Drug Products. He has served as acting director since July 2002 following the promotion of Robert Meyer, MD, to Office of Drug Evaluation II director (1"The Pink Sheet" July 8, 2002, In Brief)...

Pulmonary & Allergy Drug Products Division Director Robert Meyer, MD, will become Office of Drug Evaluation II director effective June 16

Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.